The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    O'brien, Gerald Francis
    Retail Pharmacist born in January 1949
    Individual (73 offsprings)
    Officer
    2015-11-09 ~ now
    OF - director → CIF 0
  • 2
    Didlick, Philip James
    Director born in June 1976
    Individual (53 offsprings)
    Officer
    2015-11-09 ~ now
    OF - director → CIF 0
  • 3
    O'brien, Padraic Marc
    Director born in June 1979
    Individual (53 offsprings)
    Officer
    2015-11-09 ~ now
    OF - director → CIF 0
  • 4
    Ayrton House, Commerce Way, Liverpool, England
    Corporate (4 parents, 7 offsprings)
    Equity (Company account)
    -259,995 GBP2023-12-31
    Person with significant control
    2024-01-19 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 4
  • 1
    Bromiley, Mark
    Finance Director born in September 1979
    Individual (6 offsprings)
    Officer
    2021-07-02 ~ 2025-04-01
    OF - director → CIF 0
    Bromiley, Mark
    Individual (6 offsprings)
    Officer
    2021-07-02 ~ 2025-04-01
    OF - secretary → CIF 0
  • 2
    Mr Gerald Francis O'brien
    Born in January 1949
    Individual (73 offsprings)
    Person with significant control
    2016-07-27 ~ 2024-01-19
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 3
    Didlick, Philip
    Individual (53 offsprings)
    Officer
    2015-11-09 ~ 2021-07-02
    OF - secretary → CIF 0
  • 4
    Mrs Brigid Christina Obrien
    Born in December 1946
    Individual (27 offsprings)
    Person with significant control
    2016-07-27 ~ 2024-01-19
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

PHARMASERVE (NORTH WEST) DEVELOPMENT COMPANY LIMITED

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Intangible Assets
Goodwill
51,937 GBP2023-12-31
62,324 GBP2022-12-31
Other
2,126,836 GBP2023-12-31
2,368,651 GBP2022-12-31
Intangible Assets
2,178,773 GBP2023-12-31
2,430,975 GBP2022-12-31
Debtors
85,672 GBP2023-12-31
2,178 GBP2022-12-31
Cash at bank and in hand
154 GBP2023-12-31
244 GBP2022-12-31
Current Assets
85,826 GBP2023-12-31
2,422 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-1,574,322 GBP2023-12-31
-1,483,456 GBP2022-12-31
Net Current Assets/Liabilities
-1,488,496 GBP2023-12-31
-1,481,034 GBP2022-12-31
Total Assets Less Current Liabilities
690,277 GBP2023-12-31
949,941 GBP2022-12-31
Net Assets/Liabilities
137,001 GBP2023-12-31
363,729 GBP2022-12-31
Equity
Called up share capital
1 GBP2023-12-31
1 GBP2022-12-31
Retained earnings (accumulated losses)
137,000 GBP2023-12-31
363,728 GBP2022-12-31
Equity
137,001 GBP2023-12-31
363,729 GBP2022-12-31
Average Number of Employees
02023-01-01 ~ 2023-12-31
02022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Net goodwill
103,872 GBP2023-12-31
103,872 GBP2022-12-31
Other than goodwill
2,815,045 GBP2023-12-31
2,781,581 GBP2022-12-31
Intangible Assets - Gross Cost
2,918,917 GBP2023-12-31
2,885,453 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
51,935 GBP2023-12-31
41,548 GBP2022-12-31
Other than goodwill
688,209 GBP2023-12-31
412,930 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
740,144 GBP2023-12-31
454,478 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
10,387 GBP2023-01-01 ~ 2023-12-31
Other than goodwill
275,279 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
285,666 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Net goodwill
51,937 GBP2023-12-31
62,324 GBP2022-12-31
Other than goodwill
2,126,836 GBP2023-12-31
2,368,651 GBP2022-12-31
Other Debtors
Amounts falling due within one year
85,672 GBP2023-12-31
2,178 GBP2022-12-31
Trade Creditors/Trade Payables
Current
73,009 GBP2023-12-31
39,454 GBP2022-12-31
Amounts owed to group undertakings
Current
1,374,040 GBP2023-12-31
1,440,397 GBP2022-12-31
Other Creditors
Current
127,273 GBP2023-12-31
3,605 GBP2022-12-31
Creditors
Current
1,574,322 GBP2023-12-31
1,483,456 GBP2022-12-31
  • PHARMASERVE (NORTH WEST) DEVELOPMENT COMPANY LIMITED
    Info
    Registered number 09863420
    Ayrton Saunders House Parliament Business Park, Commerce Way, Liverpool L8 7BA
    Private Limited Company incorporated on 2015-11-09 (9 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-25
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.